Toggle navigation
Home
Search
Services
Blog
Contact
About
Characterization of Human Centromeric Regions
Jabs, Ethylin Wang
Johns Hopkins University, Baltimore, MD, United States
Search 136 grants from Ethylin Jabs
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Actin Mechanisms of Postsynaptic Structure and Function
Cocaine and Regulation of the Dopamine Transporter
Approach and Avoidance - Dispositions and Daily Events
Viral Proteins That Inhibit Tnf Cytolysis
Clinical Development of Anticancer Agents
Recently added grants:
Transcutaneous vagal nerve stimulation improvement of sleep quality in veterans with PTSD with or without history of mild TBI
Social Assistive Robot Interface for People with Alzheimer's and Other Dementias to Aid in Care Management
Geriatric Oncology: Cognition and Communication
Biofunctional sealant with peptides to extend lifespans of Class V restorations
Maximizing Effectiveness of Case Management in Primary Care for Rural Veterans
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Unknown (R23)
Project #
5R23HD019074-03
Application #
3448030
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1984-08-01
Project End
1987-07-31
Budget Start
1986-08-01
Budget End
1987-07-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 1986
R23 HD
Characterization of Human Centromeric Regions
Jabs, Ethylin Wang / Johns Hopkins University
NIH 1985
R23 HD
Characterization of Human Centromeric Regions
Jabs, Ethylin Wang / Johns Hopkins University
Comments
Be the first to comment on Ethylin Jabs's grant